603360 Stock Overview
Produces and sells bactericides, antiseptics, and fungicides for various industrial applications in Europe, North and South Americas, the Middle East, Africa, and Asia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
My Notes
Capture your thoughts, links and company narrative
Dalian BIO-CHEM Company Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥22.25 |
| 52 Week High | CN¥29.80 |
| 52 Week Low | CN¥5.64 |
| Beta | 0.54 |
| 1 Month Change | 6.46% |
| 3 Month Change | 42.26% |
| 1 Year Change | 190.58% |
| 3 Year Change | 225.45% |
| 5 Year Change | 71.36% |
| Change since IPO | 172.48% |
Recent News & Updates
Shareholders Are Optimistic That Dalian BIO-CHEM (SHSE:603360) Will Multiply In Value
Oct 29
Market Might Still Lack Some Conviction On Dalian BIO-CHEM Company Limited (SHSE:603360) Even After 29% Share Price Boost
Oct 01Recent updates
Shareholders Are Optimistic That Dalian BIO-CHEM (SHSE:603360) Will Multiply In Value
Oct 29Market Might Still Lack Some Conviction On Dalian BIO-CHEM Company Limited (SHSE:603360) Even After 29% Share Price Boost
Oct 01Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Sep 26These 4 Measures Indicate That Dalian BIO-CHEM (SHSE:603360) Is Using Debt Reasonably Well
Jun 12Returns on Capital Paint A Bright Future For Dalian BIO-CHEM (SHSE:603360)
Apr 23Dalian BIO-CHEM Company Limited (SHSE:603360) Surges 41% Yet Its Low P/E Is No Reason For Excitement
Apr 01Here's Why Dalian BIO-CHEM (SHSE:603360) Can Manage Its Debt Responsibly
Mar 08Shareholder Returns
| 603360 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | 1.8% | 0.1% | 1.0% |
| 1Y | 190.6% | -4.1% | 8.2% |
Return vs Industry: 603360 exceeded the CN Chemicals industry which returned -4.1% over the past year.
Return vs Market: 603360 exceeded the CN Market which returned 8.2% over the past year.
Price Volatility
| 603360 volatility | |
|---|---|
| 603360 Average Weekly Movement | 10.3% |
| Chemicals Industry Average Movement | 7.6% |
| Market Average Movement | 8.1% |
| 10% most volatile stocks in CN Market | 12.2% |
| 10% least volatile stocks in CN Market | 5.1% |
Stable Share Price: 603360's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 603360's weekly volatility (10%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2003 | 701 | Hailong Liu | www.biofc.com |
Dalian BIO-CHEM Company Limited produces and sells bactericides, antiseptics, and fungicides for various industrial applications in Europe, North and South Americas, the Middle East, Africa, and Asia. The company’s products are used as disinfection; algaecide in water treatment, such as petrochemicals, electricity, central air conditioning, and industrial cooling water; anti-corrosion in emulsions, mineral slurries, pigment dispersions, adhesives, tackifiers, metalworking fluids, and cosmetics aqueous system; and aqueous system of leather, paint and coating, textile, and dyeing. Its products also used for anti-mildew and anti-algae applications, as well as manufactures dry film preservative, which is used for paints and coatings.
Dalian BIO-CHEM Company Limited Fundamentals Summary
| 603360 fundamental statistics | |
|---|---|
| Market cap | CN¥11.30b |
| Earnings (TTM) | CN¥299.66m |
| Revenue (TTM) | CN¥1.11b |
36.7x
P/E Ratio9.9x
P/S RatioIs 603360 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603360 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.11b |
| Cost of Revenue | CN¥606.46m |
| Gross Profit | CN¥503.95m |
| Other Expenses | CN¥204.29m |
| Earnings | CN¥299.66m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 25, 2025
| Earnings per share (EPS) | 0.61 |
| Gross Margin | 45.38% |
| Net Profit Margin | 26.99% |
| Debt/Equity Ratio | 9.2% |
How did 603360 perform over the long term?
See historical performance and comparisonDividends
1.9%
Current Dividend Yield71%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/31 09:18 |
| End of Day Share Price | 2024/12/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Dalian BIO-CHEM Company Limited is covered by 7 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andy Liu | China Stock Investment Research Co. Ltd. (GZ500..com) |
| Zhe Wang | Citic Securities Co., Ltd. |
| Wei Liu | Haitong International Research Limited |